Aarti Drugs Limited — Important, 04-02-2025: General Updates

Aarti Drugs Limited has entered into a Share Subscription and Shareholders’ Agreement with Prozeal Green Power Private Limited and Pro-Zeal Green Power Nine Private Limited. The company will acquire a 26.25% equity stake and voting rights along with compulsory convertible debentures in the latter, a Special Purpose Vehicle (SPV) aimed at developing a 24.40 MWp solar power plant to meet part of the company's energy needs. This initiative reflects Aarti Drugs' commitment to renewable energy procurement. The total investment amounts to ₹8.05 crore (cr), comprising ₹0.63 cr for equity shares and ₹7.99 cr for convertible debentures, expected to be completed within 30 days. The transaction is structured at arm's length, with potential implications for cost reduction and sustainable energy sourcing for the company. Investors should monitor this strategic move as it aligns with green energy goals and may optimize operational efficiencies going forward.